-
Watch List: Anika Therapeutics Inc. (NASDAQ:ANIK), ICF International Inc. (NASDAQ:ICFI), Agree Realty Corp. (NYSE:ADC), Meadowbrook Insurance Group Inc. (NYSE:MIG), Limoneira Company (NASDAQ:LMNR)
On Thursday shares of Anika Therapeutics Inc. (NASDAQ:ANIK) closed at $35.45. Company’s sales growth for last 5 years was 21.40% and EPS growth for next 5 years is recorded as 30.00%. Northland Securities assumed coverage on shares of Anika Therapeutics (NASDAQ:ANIK) in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm issued an outperform rating…
-
Watch List: Kohl’s Corp. (NYSE:KSS), Anika Therapeutics Inc. (NASDAQ:ANIK), Panhandle Oil and Gas Inc. (NYSE:PHX), Inventure Foods (NASDAQ:SNAK), General Cable (NYSE:BGC)
On Thursday shares of Kohl’s Corp. (NYSE:KSS) closed at $64.62. Company’s sales growth for last 5 years was 2.10% and EPS growth for next 5 years is recorded as 9.20%. Kohl’s Corp. (NYSE:KSS) reported a better-than-expected profit for its first quarter, but its revenue and a key sales measure fell short of Wall Street forecasts.…
-
Investors Alert: Anika Therapeutics Inc. (NASDAQ:ANIK), Fidelity National Financial (NYSE:FNF), Peabody Energy Corp. (NYSE:BTU), Sunstone Hotel Investors (NYSE:SHO), Caesars Entertainment (NASDAQ:CZR)
Anika Therapeutics Inc. (NASDAQ:ANIK) in last trading activity increased 0.46% to close at $35.00. Company weekly performance is -5.02% while its quarterly performance stands at -11.84%. Anika Therapeutics Inc. (NASDAQ:ANIK) is -31.91% away from its 52 week high. On Apr 28, Anika Therapeutics Inc. (NASDAQ:ANIK) reported financial results for the quarter ended March 31, 2015.…
-
Active Stocks to Watch: Anika Therapeutics Inc. (NASDAQ:ANIK), BioSpecifics Technologies Corp. (NASDAQ:BSTC), Visa Inc. (NYSE:V), Gilead Sciences Inc. (NASDAQ:GILD), Heartware International(NASDAQ:HTWR)
On Thursday shares of Anika Therapeutics Inc. (NASDAQ:ANIK) closed at $34.12. Company’s sales growth for last 5 years was 21.40% and EPS growth for next 5 years is recorded as 30.00%. Anika Therapeutics, Inc. (NASDAQ:ANIK), announced that seven abstracts related to our Hyalofast product are scheduled for presentation at the 12th Annual World Congress of…
-
Top News: U.S. Bancorp (NYSE:USB), Anika Therapeutics Inc. (NASDAQ:ANIK), Ellomay Capital (NYSEMKT:ELLO), Deutsche Bank AG (NYSE:DB), Ossen Innovation Co., (NASDAQ:OSN)
On Friday shares of U.S. Bancorp (NYSE:USB) closed at $42.74. Company’s sales growth for last 5 years was 1.20% and EPS growth for next 5 years is recorded as 6.51%. On April 21, U.S. Bancorp (NYSE:USB) has named John Hyatt to lead the U.S. Bank Indirect Lending Group, which provides loans and leases to consumers…
-
Investors Watch List: Aegerion Pharmaceuticals (NASDAQ:AEGR), Anika Therapeutics Inc. (NASDAQ:ANIK), Otter Tail Corporation (NASDAQ:OTTR), Charter Communications (NASDAQ:CHTR), RenaissanceRe Holdings (NYSE:RNR)
On Monday shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) closed at $25.95. Company’s EPS growth for next 5 years is recorded as 5.10%. On Apr 09, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), has appointed Jorge Plutzky, M.D., to its Board of Directors, effective immediately. Dr. Plutzky will serve as a Class I director and will be up for…
-
Stocks to Watch: ArcelorMittal SA (ADR) (NYSE:MT), Bank of America Corporation (NYSE:BAC), Anika Therapeutics (NASDAQ:ANIK), La Jolla Pharmaceutical (NASDAQ:LJPC), Owens-Illinois (NYSE:OI)
On Friday shares of ArcelorMittal SA (ADR) (NYSE:MT) closed at $10.08. Company’s sales growth for last 5 years was 5.40%. ArcelorMittal SA (NYSE:MT) has been given a “BB+” credit rating by Morningstar. The investment research firm’s “BB+” rating indicates that the company is an above-average default risk. They also gave their stock a five star…
-
Watch List: Amicus Therapeutics (NASDAQ:FOLD), AVEO Pharmaceuticals (NASDAQ:AVEO), Yahoo! Inc. (NASDAQ:YHOO), Anika Therapeutics Inc. (NASDAQ:ANIK), China Lodging Group, Limited (NASDAQ:HTHT)
On Thursday shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) closed at $12.46. Company’s sales growth for last 5 years was -54.90%. Amicus Therapeutics Inc. (NASDAQ:FOLD) plans to file for accelerated approval of its experimental treatment for a rare, inherited disease following meetings with regulators in the U.S. and Europe. In the U.S., the company plans to…
-
Morning Buzz: Delta Air Lines (NYSE:DAL), Anika Therapeutics Inc. (NASDAQ:ANIK), ACE Limited (NYSE:ACE), Tesla Motors Inc (NASDAQ:TSLA), Galena Biopharma Inc (NASDAQ:GALE)
On Tuesday shares of Delta Air Lines, Inc. (NYSE:DAL) closed at $46.65. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 19.88%. Delta Air Lines, Inc. (NYSE:DAL) said carriers based in the Persian Gulf are receiving subsidies worth tens of billions of dollars from the…